Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Molecular Neurobiology|August 4, 2005
Novel eicosanoid pathways: the discovery of prostacyclin/6-keto prostaglandin F1alpha and the hepoxilinsCecil R Pace-Asciak
Cancer Metastasis Reviews|October 19, 2011
Hepoxilins in cancer and inflammation--use of hepoxilin antagonistsCecil R Pace-Asciak
Biochimica Et Biophysica Acta|September 22, 2014
Pathophysiology of the hepoxilinsCecil R Pace-Asciak
British Journal of Pharmacology|May 9, 2009
The hepoxilins and some analogues: a review of their biologyCecil R Pace-Asciak
In Vivo (Athens, Greece)|April 18, 2007
Hepoxilin analogs, PBT-3 and PBT-4, cause apoptosis of Gleevec-resistant K562 cells in vitroNa Qiao, Denis Reynaud, Mohamed Abdelhaleem, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 19, 2002
A new family of thromboxane receptor antagonists with secondary thromboxane synthase inhibitionCecil R Pace-Asciak, Denis Reynaud, Peter Demin, et al.
In Vivo (Athens, Greece)|March 31, 2005
The hepoxilin analog, PBT-3, inhibits growth of K-562 CML solid tumours in vivo in nude miceXiang Li, Na Qiao, Denis Reynaud, et al.
Biochemical and Biophysical Research Communications|August 17, 2005
PBT-3, a hepoxilin stable analog, causes long term inhibition of growth of K562 solid tumours in vivoXiang Li, Na Qiao, Denis Reynaud, et al.
Anticancer Research|December 12, 2003
The hepoxilin analog PBT-3 induces apoptosis in BCR-ABL-positive K562 leukemia cellsNa Qiao, Janice Lam, Denis Reynaud, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 16, 2003
The thromboxane receptor antagonist PBT-3, a hepoxilin stable analog, selectively antagonizes the TPalpha isoform in transfected COS-7 cellsNa Qiao, Denis Reynaud, Peter Demin, et al.
Pageof 2